Correlation Between Dupont De and Halozyme Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dupont De and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Halozyme Therapeutics, you can compare the effects of market volatilities on Dupont De and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Halozyme Therapeutics.
Diversification Opportunities for Dupont De and Halozyme Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dupont and Halozyme is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Halozyme Therapeutics go up and down completely randomly.
Pair Corralation between Dupont De and Halozyme Therapeutics
Allowing for the 90-day total investment horizon Dupont De is expected to generate 2.35 times less return on investment than Halozyme Therapeutics. But when comparing it to its historical volatility, Dupont De Nemours is 1.69 times less risky than Halozyme Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Halozyme Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 3,306 in Halozyme Therapeutics on August 27, 2024 and sell it today you would earn a total of 1,594 from holding Halozyme Therapeutics or generate 48.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Halozyme Therapeutics
Performance |
| Timeline |
| Dupont De Nemours |
| Halozyme Therapeutics |
Dupont De and Halozyme Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Halozyme Therapeutics
The main advantage of trading using opposite Dupont De and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.| Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide | Dupont De vs. LyondellBasell Industries NV |
| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |